Brice Ludwig

Brice Ludwig, Ph.D., currently serves as a Scientist II in Bioconjugation at Abzena, starting in December 2023. Prior to this role, Brice Ludwig was a Graduate Research Assistant and PhD Candidate in the research group of Dr. Neal Zondlo at the University of Delaware from January 2016 to November 2023, focusing on novel solid-phase synthetic methodologies and optimized ligation strategies. Earlier experience includes internships at Firmenich, where research involved cell-based assay development and efficacy enhancement, and ImClone Systems, where Brice Ludwig contributed to a cancer immunology drug discovery project involving solid-phase and cell-based immunoassays. Brice Ludwig holds a PhD in Biochemistry from the University of Delaware and a BS in Biochemistry from SUNY Geneseo.